PULSION Medical Systems SE, together with its subsidiaries, develops, manufactures, and sells systems to monitor, diagnose, and manage the physical parameters of seriously ill and intensive care patients worldwide. The company also produces and markets intravenous diagnostics and sterile disposable items used to monitor patients. It operates in two business units, Critical Care and Perfusion. The company offers PiCCO2 platform, which is used in intensive medical care for treating critically ill patients; PulsioFlex platform that provides technology for use in perioperative medicine; and PiCCO catheter that enables doctors and medical practitioners to monitor the cardiovascular systems of intensive care patients, and to manage the selected therapy. It also provides ProAQT technology, which is used on high-risk patients and during high-risk procedures primarily in the operating room; CeVOX technology that monitors oxygen balance; and LiMON technology to evaluate and monitor liver function. In addition, the company offers ICG PULSION, which is injected into the circulatory system to allow superficial vessels to be visualized; and Photodynamic Eye, a camera unit that is used in various surgical areas. PULSION Medical Systems SE was founded in 1990 and is headquartered in Feldkirchen, Germany.
pulsion medical systems-reg (PUS:Xetra)
Phone: 49 89 459 9140
Fax: 49 89 4599 1418www.pulsion.com
|Deltex Medical Group PLC||10.38 GBp||0.00|
|Edwards Lifesciences Corp||$87.94 USD||-0.21|
|ICU Medical Inc||$61.27 USD||+0.47|
|LiDCO Group PLC||17.75 GBp||0.00|
|View Industry Companies|
Sponsored Financial Commentaries
To contact PULSION MEDICAL SYSTEMS-REG, please visit www.pulsion.com. Company data is provided by Capital IQ. Please use this form to report any data issues.